EUROFINS SCIENT EBITDA 2018-2024 | ERFSF

EUROFINS SCIENT annual and quarterly EBITDA history from 2018 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • EUROFINS SCIENT EBITDA for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • EUROFINS SCIENT EBITDA for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
  • EUROFINS SCIENT 2024 annual EBITDA was $1.46B, a 18.12% increase from 2023.
  • EUROFINS SCIENT 2023 annual EBITDA was $1.236B, a 8.57% decline from 2022.
  • EUROFINS SCIENT 2022 annual EBITDA was $1.352B, a 33.28% decline from 2021.
EUROFINS SCIENT Annual EBITDA
(Millions of US $)
2024 $1,460
2023 $1,236
2022 $1,352
2021 $2,027
2020 $1,407
2019 $866
2018 $703
2017 $553
2016 $2,762
2015 $0
EUROFINS SCIENT Quarterly EBITDA
(Millions of US $)
2024-12-31
2023-06-30
2022-12-31
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2019-06-30
2018-12-31
2018-06-30
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $13.895B $7.522B
Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $138.339B 25.95
CVS Health (CVS) United States $80.708B 10.03
Elevance Health (ELV) United States $77.846B 10.05
Cencora (COR) United States $57.726B 20.08
DiDi Global (DIDIY) China $28.851B 30.65
Labcorp Holdings (LH) United States $20.589B 16.70
Natera (NTRA) United States $20.264B 0.00
BioMerieux (BMXMF) France $16.861B 0.00
CochLear (CHEOY) Australia $12.835B 0.00
Solventum (SOLV) United States $12.635B 13.38
ICON (ICLR) Ireland $11.632B 10.81
Revvity (RVTY) United States $11.186B 19.25
Viatris (VTRS) United States $10.657B 3.66
Medpace Holdings (MEDP) United States $9.049B 24.03
Sonic Healthcare (SKHHY) Australia $8.827B 0.00
Avantor (AVTR) United States $8.763B 12.73
HealthEquity (HQY) United States $8.446B 37.00
Caris Life Sciences,�Inc (CAI) United States $7.988B 0.00
Charles River Laboratories (CRL) United States $7.610B 14.91
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.943B 29.10
BrightSpring Health Services (BTSG) United States $3.527B 32.35
Sotera Health (SHC) United States $3.188B 18.11
Surgery Partners (SGRY) United States $2.902B 37.73
Alignment Healthcare (ALHC) United States $2.649B 0.00
Concentras Parent (CON) United States $2.522B 14.58
Organon (OGN) United States $2.503B 2.66
GeneDx Holdings (WGS) United States $2.296B 88.43
Progyny (PGNY) United States $1.973B 43.43
PACS (PACS) United States $1.882B 0.00
Premier (PINC) United States $1.730B 13.13
Ardent Health (ARDT) United States $1.718B 7.32
GoodRx Holdings (GDRX) United States $1.700B 34.00
Teladoc Health (TDOC) United States $1.382B 0.00
Establishment Labs Holdings (ESTA) $1.263B 0.00
Pediatrix Medical (MD) United States $1.101B 8.38
CareDx (CDNA) United States $1.069B 16.70
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Agilon Health (AGL) United States $0.894B 0.00
QDM (QDMI) Hong Kong, SAR China $0.848B 291.00
AMN Healthcare Services Inc (AMN) United States $0.754B 7.06
InnovAge Holding (INNV) United States $0.590B 0.00
Nutex Health (NUTX) United States $0.578B 8.75
Embecta (EMBC) United States $0.570B 3.84
SBC Medicals (SBC) United States $0.543B 0.00
So-Young (SY) China $0.530B 0.00
LifeMD (LFMD) United States $0.514B 0.00
Omada Health (OMDA) $0.476B 0.00
Auna S.A (AUNA) Luxembourg $0.474B 10.67
Sonida Senior Living (SNDA) United States $0.473B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.368B 0.00
Enhabit (EHAB) United States $0.346B 28.50
Performant Healthcare (PHLT) United States $0.318B 0.00
Oncology Institute (TOI) United States $0.288B 0.00
Beauty Health (SKIN) United States $0.217B 0.00
DocGo (DCGO) United States $0.145B 23.67
Pheton Holdings (PTHL) China $0.138B 0.00
Sera Prognostics (SERA) United States $0.112B 0.00
Ascend Wellness Holdings (AAWH) United States $0.074B 0.00
KindlyMD (NAKA) United States $0.069B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.060B 0.00
Basel Medical Group (BMGL) Singapore $0.050B 0.00
Biodesix (BDSX) United States $0.045B 0.00
ModivCare (MODV) United States $0.042B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.036B 0.00
OSR Holdings (OSRH) United States $0.020B 0.00
Intelligent Bio Solutions (INBS) United States $0.015B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.008B 0.00
SeaStar Medical Holding (ICU) United States $0.007B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00